We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SOME DRUGS COULD BE LEFT OUT UNDER PROPOSED USP GUIDELINES
SOME DRUGS COULD BE LEFT OUT UNDER PROPOSED USP GUIDELINES
August 27, 2004
According to at least one pharmaceutical analyst, the U.S. Pharmacopeia’s (USP’s) proposed guidelines for developing Medicare drug formularies could make it difficult for some brand products to make the cut.